| Andrea Lynn Oswald, SLP | |
|
3105 N Wilke Rd Ste H, Arlington Heights, IL 60004-1450 | |
| (847) 255-8690 | |
| (847) 255-2260 |
| Full Name | Andrea Lynn Oswald |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3105 N Wilke Rd Ste H, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568654531 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Lynn Oswald, SLP 444 W Fullerton Pkwy Apt 1203, Chicago, IL 60614-3992 Ph: () - | Andrea Lynn Oswald, SLP 3105 N Wilke Rd Ste H, Arlington Heights, IL 60004-1450 Ph: (847) 255-8690 |
News Archive
Hospitalar—Welch Allyn, a leading global manufacturer of frontline medical products and solutions, is reconfirming its commitment to caregivers in Latin America with innovative solutions to healthcare issues that are unique to the region. In March 2009 the company acquired MD International (MDI), now Welch Allyn Latin America, and has since gained significant market share in South and Central America, Mexico and the Caribbean thanks to strong relationships with large distribution and manufacturer partners.
The Neuroendocrine Tumor Research Foundation today announced its largest research commitment ever - $4 million in collaborative grants - most from its new Accelerator Grants program to study neuroendocrine tumors, a widely misunderstood, commonly misdiagnosed cancer type, without adequately identified genomic drivers.
Meda has reached an agreement with Valeant to terminate the companies' joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda affiliates have been established.
An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer. The findings are being presented at the annual meeting of the American Society of Clinical Oncology.
Pharmacyclics, Inc. today reported financial results for its fiscal year and fourth quarter which ended June 30, 2010.
› Verified 6 days ago
Mrs. Megan Brazas, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 W Maude Ave, Arlington Heights, IL 60004 Phone: 630-329-2389 | |
Mrs. Gloria S Vosburgh, M. ED. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 E Ivy Ln, Arlington Heights, IL 60004 Phone: 847-253-9470 | |
Christine Anne Loprest, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2211 N Burke Dr, Arlington Heights, IL 60004 Phone: 847-398-4275 | |
Judith Ildiko Jokay, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1315 E Miner St, Arlington Heights, IL 60004 Phone: 847-398-4297 | |
Miss Aimee Rose Leblanc, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Dunton Ave, Arlington Heights, IL 60005 Phone: 847-758-7958 | |
Amy Leigh Sarna, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 S Goebbert Rd, Arlington Heights, IL 60005 Phone: 847-718-4965 | |
Julie M. Wyss, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Central Rd, Arlington Heights, IL 60005 Phone: 847-506-3482 |